E70.338
Other albinism with hematologic abnormality
Clinical Classification Guidelines
Medical Intelligence & Overview
Other albinism with hematologic abnormality, classified under ICD-10 code E70.338, refers to a rare genetic condition characterized by a lack of pigment in the skin, hair, and eyes accompanied by blood-related abnormalities. This condition combines features of albinism—a disorder that affects melanin production—with hematologic problems, which involve issues with blood components. Individuals with this diagnosis experience a combination of visual, skin, and hematologic symptoms that require ongoing management and monitoring.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting melanin production pathways Inherited conditions passed down through families Mutations influencing blood cell development or function Possible interactions between genetic factors causing both albinism and hematologic abnormalities
Key Symptoms: Light-colored or white skin, hair, and eye pigmentation Vision problems such as reduced visual acuity, nystagmus, or photophobia Increased susceptibility to sunburn and skin damage Blood abnormalities which may include anemia, abnormal blood cell counts, or clotting issues Bleeding tendencies or easy bruising Fatigue, weakness, or shortness of breath related to blood issues
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive evaluation including detailed medical history, physical examination, and specific laboratory tests. These typically include:
Treatment Protocols: Management of other albinism with hematologic abnormality focuses on treating the symptoms and preventing complications. Typical approaches include:
Clinical Advice & FAQs
Billing Guidance
Is E70.338 a billable ICD-10 code?
Yes, E70.338 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E70.338?
Clinical documentation must specify the nature of Other albinism with hematologic abnormality and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
